3D Virtual Resection for Predicting Lung Function in VATS
- Sponsor
- National Taiwan University Hospital
- Study ID
- NCT07436598
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
This study aims to validate a novel preoperative assessment strategy using three-dimensional (3-D) computed tomography (CT) reconstruction and virtual resection simulation. The goal is to accurately predict postoperative pulmonary function in patients with non-small cell lung cancer (NSCLC) undergoing Video-Assisted Thoracoscopic Surgery (VATS) anatomical resection. Accurate prediction of postoperative lung function is crucial for patient safety. Traditional methods, such as segment counting, often lack precision because they assume all lung segments contribute equally to function, ignoring variations caused by tumors or emphysema. This study utilizes 3-D "virtual resection" to quantify the "Planned Resected Ventilated Lung Volume Fraction" (pRVLVF) before surgery. The study will recruit 60 participants divided into two groups: those undergoing lobectomy (n=30) and those undergoing segmentectomy (n=30). Participants will undergo standard thin-slice CT scans and pulmonary function tests (PFT) before surgery. Postoperatively, lung function and recovery will be tracked at 3, 6, and 12 months to develop a dynamic prediction model and evaluate the compensatory capacity of the residual lung.
Key Dates
- First listed
- Feb 27, 2026
- Start date
- Apr 7, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: VATS Segmentectomy GroupPatients with non-small cell lung cancer scheduled to undergo video-assisted thoracoscopic segmentectomy.
- Arm: VATS Lobectomy GroupPatients with non-small cell lung cancer scheduled to undergo video-assisted thoracoscopic lobectomy.
Primary Outcome Measure
Mean Absolute Error (MAE) of Predicted Postoperative FEV1 [ Time Frame: 3 months post-operation ]
Central Contacts
- Chih-Hsiang Chang, MD+886-0972653384
Find similar trials
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania